60 Degrees Pharmaceuticals (SXTP) Total Current Liabilities (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Total Current Liabilities of $1.9 million for Q1 2026, up 4.06% year-over-year from $1.8 million in Q1 2025, and up 1.78% quarter-over-quarter from $1.8 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Total Current Liabilities (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Total Current Liabilities for 5 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 4.06% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (up 4.06% YoY), while the FY2025 annual figure was $1.8 million, up 11.2% from the prior year.
- Total Current Liabilities rose to $1.9 million in Q1 2026 per SXTP's latest filing, from $1.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $28.9 million in Q2 2023 and bottomed at $1.1 million in Q1 2024.
- Historically, Total Current Liabilities has averaged $5.6 million across 5 years, with a median of $1.8 million in 2025.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 95.78% — and 2025, when it surged 67.72%.
- 60 Degrees Pharmaceuticals' Total Current Liabilities stood at $23.9 million in 2022, then tumbled by 88.15% to $2.8 million in 2023, then slumped by 41.55% to $1.7 million in 2024, then gained by 11.2% to $1.8 million in 2025, then advanced by 1.78% to $1.9 million in 2026.
- Business Quant data shows SXTP's Total Current Liabilities at $1.9 million in Q1 2026, $1.8 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 28.86 Mn |
| Dec 31, 2022 | 23.92 Mn |